We are live on ! Find out more
Raymond James Financial

Raymond James Financial Portfolio holdings

AUM $324B
1-Year Est. Return 22.36%
 

Raymond James Financial, founded in 1962 by Robert James and headquartered in St. Petersburg, Florida, is a diversified financial services firm managing over $1.5 trillion in client assets as of late 2024, primarily focused on wealth management, investment banking, and brokerage services. Known for its advisor-centric model, the firm supports over 8,900 financial advisors across the U.S., Canada, and the UK, offering personalized financial planning, retirement solutions, and investment products to individuals, small businesses, and institutions. Its investment banking arm specializes in middle-market mergers, acquisitions, and equity offerings, while its Raymond James Bank provides lending and deposit services. With a reputation for a conservative, client-first culture and steady growth—including a notable acquisition of TriState Capital in 2022—Raymond James stands out as a resilient, relationship-driven player in the financial industry.

This Fund
S&P 500
This Quarter Est. Return
+10.68%
1 Year Est. Return
+22.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$290B
AUM Growth
+$24.8B
Cap. Flow
+$3.19B
Cap. Flow %
1.1%
Top 10 Hldgs %
21.85%
Holding
7,081
New
2,185
Increased
2,404
Reduced
2,172
Closed
80

Top Buys

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$962M
2
ABBV icon
AbbVie
ABBV
+$512M
3
BAC icon
Bank of America
BAC
+$172M
4
TJX icon
TJX Companies
TJX
+$157M
5
GEV icon
GE Vernova
GEV
+$156M

Sector Composition

Rank Sector Weight
1 Technology 16.54%
2 Financials 9.27%
3 Industrials 6.9%
4 Healthcare 6.27%
5 Consumer Discretionary 6.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SDOT icon
6651
Sadot Group
SDOT
$13.1M
$264 ﹤0.01%
+1
New +$313
CD
6652
Chaince Digital Holdings
CD
$226M
$262 ﹤0.01%
+68
New +$343
PANL icon
6653
Pangaea Logistics
PANL
$480M
$259 ﹤0.01%
+55
New +$244
EVGN icon
6654
Evogene
EVGN
$7.65M
$256 ﹤0.01%
+200
New +$245
REBN icon
6655
Reborn Coffee
REBN
$11.7M
$254 ﹤0.01%
+100
New +$282
AMIX
6656
Autonomix Medical
AMIX
$5.1M
$254 ﹤0.01%
+8
New +$287
TNXP icon
6657
Tonix Pharmaceuticals
TNXP
$201M
$252 ﹤0.01%
+7
New +$183
CLYM
6658
Climb Bio
CLYM
$775M
$248 ﹤0.01%
+200
New +$249
OCG icon
6659
Oriental Culture Holding
OCG
$3.39M
0
BNGO icon
6660
Bionano Genomics
BNGO
$13.4M
$243 ﹤0.01%
+74
New +$276
SYRE icon
6661
Spyre Therapeutics
SYRE
$9.28B
$240 ﹤0.01%
+16
New +$237
INKT icon
6662
MiNK Therapeutics
INKT
$54.6M
$236 ﹤0.01%
+32
New +$241
BEEM icon
6663
Beam Global
BEEM
$25.5M
$235 ﹤0.01%
+161
New +$257
VVOS icon
6664
Vivos Therapeutics
VVOS
$4.44M
$234 ﹤0.01%
+74
New +$187
SER icon
6665
Serina Therapeutics
SER
$40.9M
$234 ﹤0.01%
+38
New +$216
VALN
6666
Valneva
VALN
$538M
$232 ﹤0.01%
+41
New +$260
MGX icon
6667
Metagenomi Therapeutics
MGX
$46.7M
$232 ﹤0.01%
+157
New +$246
PYPD icon
6668
PolyPid
PYPD
$92M
$229 ﹤0.01%
+65
New +$190
SBEV icon
6669
Splash Beverage Group
SBEV
$2.58M
$229 ﹤0.01%
+15
New +$246
BTAI icon
6670
BioXcel Therapeutics
BTAI
$28.5M
$226 ﹤0.01%
+125
New +$207
ZKIN icon
6671
ZK International Group
ZKIN
$63M
$225 ﹤0.01%
+109
New +$209
MYO icon
6672
Myomo
MYO
$56.6M
$222 ﹤0.01%
+103
New +$373
VRA icon
6673
Vera Bradley
VRA
$96.7M
$221 ﹤0.01%
+100
New +$206
VTAK icon
6674
Catheter Precision
VTAK
$1.1M
$220 ﹤0.01%
+48
New +$260
STHO icon
6675
Star Holdings Shares of Beneficial Interest
STHO
$115M
$219 ﹤0.01%
+28
New +$194

Similar funds

Raymond James Financial's Q2 2025 Portfolio in Review

As of Q2 2025, Raymond James Financial held 7,081 positions worth $290B, up 9.4% from $266B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Raymond James Financial's Q2 2025 filing shows 2,185 new, 2,404 increased, 2,172 reduced and 80 closed positions. Its largest new stake was ServiceTitan Inc: 369,922 shares worth $39.6M. The largest sale was Merck, an estimated $636M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.

  • Raymond James Financial's largest Q2 2025 buy was ServiceTitan Inc: 369,922 shares worth $39.6M.
  • Raymond James Financial added most to Vanguard S&P 500 ETF in Q2 2025, an estimated $962M increase.
  • Raymond James Financial's biggest Q2 2025 reduction was Merck, cutting an estimated $636M.
  • Raymond James Financial fully exited Discover Financial Services in Q2 2025, selling an estimated $36.8M.
  • Raymond James Financial's ten largest holdings make up 22% of its $290B portfolio in Q2 2025.
  • Raymond James Financial opened 2,185 new positions and closed 80 in Q2 2025.
  • Raymond James Financial's portfolio value rose 9.4% quarter-over-quarter to $290B.

Based on Raymond James Financial's 13F filing for Q2 2025, filed 14 Aug 2025.